Physician
Rheumatology
Dr. Naomi Rothfield, MD
|
|
Give Review
Naomi Rothfield, MD is an expert in the field of Rheumatology. He graduated from NYU School of Medicine. He has 3 awards "CMS Meaningful Use Stage 1 Certification", "Elected Member" and "Whos Who in Medicine and Healthcare". Naomi Rothfield, MD is a published MD. He has 100 papers published. The most current publication "Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment." Doctor Naomi Rothfield, MD is registered with Medicare.
Publications
- Hydroxychloroquine treatment in SLE.
- Exercise During Cardiac Catheterization Distinguishes Between Pulmonary and Left Ventricular Causes of Dyspnea in Systemic Sclerosis Patients.
- Effects of prasterone on Disease activity and symptoms in women with active systemic lupus erythematosus.
- Minocycline is not effective in systemic sclerosis: results of an open-label multicenter trial.
- Longitudinal study of anticentromere and antitopoisomerase-I isotypes.
- Lupus erythematosus: systemic and cutaneous manifestations.
- Bullae in systemic Lupus erythematosus.
- Absence of measles proviral DNA in systemic Lupus erythematosus.
- Efficacy of antimalarials in systemic Lupus erythematosus.
- Clinical aspects and treatment of systemic Lupus erythematosus.
- Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies.
- Patterns of nuclear fluorescence and DNA-binding activity.
- Familial partial deficiency of the third component of complement (C3) and the hypocomplementemic cutaneous vasculitis Syndrome.
- Lack of induction of antinuclear antibodies by D-penicillamine in rheumatoid Arthritis: a controlled study.
- Hypergammaglobulinemic purpura in systemic autoimmune rheumatic Diseases: predictive value of anti-Ro(SSA) and anti-La(SSB) antibodies and treatment with indomethacin ...
- Anti-endothelial Cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment.
- Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.
- A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type...
- Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial.
- Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung Disease: results from the scleroderma lung study.
- Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sc...
- Measuring Disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
- MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial.
- Range of antinuclear antibodies in "healthy" individuals.
- Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.
- A comparison of the specificity of the 1971 and 1982 American Rheumatism Association criteria for the classification of systemic Lupus erythematosus.
- Family study of systemic Lupus erythematosus: analysis of the clinical history, skin immunofluorescence, and serologic parameters.
- Demonstration of beta 1H globulin together with C3 in the dermal-epidermal junction of patients with systemic Lupus erythematosus.
- Studies of repeat skin biopsies of nonlesional skin in patients with systemic Lupus erythematosus.
- Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial.
- A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity.
- Cyclophosphamide versus placebo in scleroderma lung Disease.
- Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung Disease.
- Reference sera for antinuclear antibodies. II. Further definition of antibody specificities in international antinuclear antibody reference sera by immunofluorescence ...
- Use of molecular cloning methods to map the distribution of epitopes on topoisomerase I (Scl-70) recognized by sera of scleroderma patients.
- Clinical associations of anticentromere antibodies and antibodies to topoisomerase I. A study of 355 patients.
- Correlation of anti-Ro antibody with photosensitivity rash in systemic Lupus erythematosus patients.
- Clinical and serologic significance of cutaneous deposits in systemic Lupus erythematosus.
- The Response of cultured lymphocytes from patients with systemic lupus erythematosus to DNA.
- A comparison of the sensitivity of the 1971 and 1982 American Rheumatism Association criteria for the classification of systemic Lupus erythematosus.
- Congenital heart block, systemic Lupus erythematosus, and anti-Ro antibodies.
- The role of antinuclear reactions in the diagnosis of systemic Lupus erythematosus: a study of 53 cases.
- Serum antinuclear antibodies in progressive systemic sclerosis (scleroderma).
- An evaluation of the preliminary criteria for the diagnosis of systemic Lupus erythematosus.
- The 1982 revised criteria for the classification of systemic Lupus erythematosus.
- An epidemiologic study of households exposed to canine systemic Lupus erythematosus.
- Systemic Lupus erythematosus. Laboratory studies.
- Pathways of complement activation in Chronic discoid lupus: serologic and immunofluorescence studies.
- A simple severity of Disease index for systemic lupus erythematosus.
- Antibodies to native DNA and serum complement (C3) levels. Application to diagnosis and classification of systemic Lupus erythematosus.
- Familial Discoid lupus erythematosus associated with heterozygote C2 deficiency.
- Factors associated with low bone mineral density in female patients with systemic Lupus erythematosus.
- Clinical significance of serum properdin levels and properdin Deposition in the dermal-epidermal junction in systemic lupus erythematosus.
- Aseptic necrosis of bone in systemic Lupus erythematosus. Relationship to corticosteroid therapy.
- Nasal septal perforation in systemic Lupus erythematosus.
- Glomerular and dermal depostion of properdin in systemic Lupus erythematosus.
- Outcome measurements in scleroderma: results from a delphi exercise.
- A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. III. Comparative performance characteristics of ...
- A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody content.
- CENP-C, an autoantigen in scleroderma, is a component of the human inner kinetochore plate.
- Human autoantibody to topoisomerase II.
- Disruption of centromere assembly during interphase inhibits kinetochore morphogenesis and function in mitosis.
- Injection of anticentromere antibodies in interphase disrupts events required for chromosome movement at mitosis.
- Role of the centromere/kinetochore in Cell cycle control.
- cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment.
- Multipurpose Arthritis centers. A ten-year progress report.
- Comment on the article by Lockshin.
- The IgG, IgM, and IgA isotypes of anti-topoisomerase I and anticentromere autoantibodies.
- Isotype analysis of the anti-CENP-B anticentromere autoantibody: evidence for restricted clonality.
- Prognostic significance of anticentromere antibodies and anti-topoisomerase I antibodies in Raynaud's Disease. A prospective study.
- Aseptic necrosis presenting as wrist Pain in SLE.
- Prostaglandin E1 treatment of NZB/NZW F1 hybrid mice. II. Prevention of glomerulonephritis.
- Prostaglandin E treatment of NZB/NZW mice.
- The clinical utility of the Lupus band test.
- Sensitivity and specificity of anti-Jo-1 antibodies in autoimmune Diseases with myositis.
- RENAL Disease IN SYSTEMIC LUPUS ERYTHEMATOSUS.
- The relation of immunoglobulin class, pattern of anti-nuclear antibody, and complement-fixing antibodies to DNA in sera from patients with systemic Lupus erythematosus.
- SLOWLY SEDIMENTING MERCAPTOETHANOL-RESISTANT ANTINUCLEAR FACTORS RELATED ANTIGENICALLY TO M IMMUNOGLOBULINS (GAMMA-1M-GLOBULIN) IN PATIENTS WITH SYSTEMIC Lupus ERYTHEM...
- Selective complete Clq deficiency associated with systemic Lupus erythematosus.
- E.B. virus and other viral antibodies in systemic Lupus erythematosus.
- Immunoglobulin class and pattern of nuclear fluorescence in systemic Lupus erythematosus.
- Clinical and laboratory aspects of raised virus antibody titres in systemic Lupus erythematosus.
- Extensive calcinosis cutis with systemic Lupus erythematosus.
- Systemic Lupus erythematosus in childhood. Analysis of 42 cases, with comparative data on 200 adult cases followed concurrently.
- General considerations in the treatment of systemic Lupus erythematosus.
- Raised antibody titres to E.B. virus in systemic Lupus erythematosus.
- Systemic Lupus erythematosus in the younger patient: survival studies.
- Divergent racial trends in mortality from systemic Lupus erythematosus.
- The coexistence of rheumatoid Arthritis and systemic lupus erythematosus: a case report and review of the literature.
- Corticosteroid treatment in systemic Lupus erythematosus. Survival studies.
- The efficacy of antimalarials in systemic Lupus erythematosus.
- Racial aspects of comorbidity in systemic Lupus erythematosus.
- Etanercept-induced lupus-like syndrome in a patient with rheumatoid Arthritis.
- A comparison of self-reports of distress and affective disorder diagnoses in rheumatoid Arthritis: a receiver operator characteristic analysis.
- Anticentromere autoantibodies. Evaluation of an ELISA using recombinant fusion protein CENP-B as antigen.
- Association of anti-topoisomerase I with cancer.
- Detection of anticentromere antibodies using cloned autoantigen CENP-B.
- Anticytoskeletal autoantibodies in the connective tissue Diseases.
- A long-term longitudinal study of anticentromere antibodies.
Schools
New York University School Of Medicine
Lenox Hill Hospital
Bellevue Hospital Center
Procedures Preformed
- Joint Drainage
- Myofascial Trigger Point Injection
- Steroid Injection
- Trigger Point Injection
- View All
Conditions Treated
- Amyloidosis
- Arthritis
- Bursitis
- Calcium Pyrophosphate Dihydrate Deposition Disease (CPPD)
- View All
Doctors Specialties
- Rheumatology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Pathway X Ind PPO Direct Access CT
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Connecticare HMO
- Connecticare POS
- First Health (Coventry Health Care) PPO
- Golden Rule
- Harvard Pilgrim Health Care PPO
- Choice Care PPO
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- MVP Health Care
- Freedom Plan
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- Oxford Liberty
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
- Elected Member
- Whos Who in Medicine and Healthcare
Education
-
Lenox Hill Hospital -
NYU School of Medicine
Drug Facts
| NPI NUMBER | 1396742722 | |
| NPPES Provider LastName | ROTHFIELD | |
| NPPES Provider FirstName | NAOMI | |
| NPPES Provider ZIPCode | 060300001 | |
| NPPES Provider State | CT | |
| Specialty Description | Rheumatology | |
| Total Claim Count | 497.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1396742722 |
| Last Name Of The Provider | ROTHFIELD |
| First Name Of The Provider | NAOMI |
| View All |
Similar Doctors
|
|
Dr. James R. Seibold, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Santhanam Lakshminarayanan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melinda L. Ramsby, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Micha Abeles, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shweta Kishore, MD |
|
|
Dr. Ranadeep R. Mandhadi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aryeh M. Abeles, MD
This Doctor is OpenDoctor Recommended.
|